Alterity Therapeutics Ltd.

ATHE·NASDAQ·$4.08Share Price as of 11/2·$37MMarket Cap as of 11/2

Financials

20-FAnnual report (foreign)08/28/26 20-FAnnual report (foreign)08/29/25 20-FAnnual report (foreign)09/26/24 20-FAnnual report (foreign)08/31/23 20-FAnnual report (foreign)08/31/22

Disclosures

6-KForeign issuer report10/30/26 6-KForeign issuer report10/23/26 6-KForeign issuer report10/23/26 6-KForeign issuer report10/23/26 6-KForeign issuer report10/21/26

Prospectuses and Registrations

S-8Registration of securities for employees09/18/26 424B5Prospectus supplement02/15/24 F-3Shelf registration (foreign)10/02/23 424B3Prospectus01/06/21 F-3Shelf registration (foreign)12/23/20

Proxies

No matching filings.

Ownership

Form 4Insider transaction09/08/26 Form 4Insider transaction09/08/26 Form 4Insider transaction06/23/26 Form 4Insider transaction06/23/26 Form 3Initial insider ownership04/29/26

Other

EFFECTRequest for effectiveness10/25/23 CORRESPCorrespondence with the SEC10/23/23 UPLOADLetter from the SEC10/12/23 EFFECTRequest for effectiveness01/06/21 CORRESPCorrespondence with the SEC01/04/21